BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6239268)

  • 1. [Hypercalcemic crises of myelomatous origin. Treatment with dichloromethylene diphosphonate].
    Conte N; Di Virgilio R; Roiter I
    Presse Med; 1984 Nov; 13(42):2586. PubMed ID: 6239268
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy of intravenous dichloromethylene diphosphonate in paraneoplastic hypercalcemia resistant to mithramycin].
    Peyron R; Sereni D; Grateau G; Boissonnas A; Cremer GA; Laroche C
    Rev Rhum Mal Osteoartic; 1984; 51(7-8):435-7. PubMed ID: 6238399
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neoplastic hypercalcemia with renal insufficiency: treatment with dichloromethylene diphosphonate].
    Conte N; Di Virgilio R; Roiter I; Foscolo G; Baruffi C
    Clin Ter; 1985 Nov; 115(3):177-80. PubMed ID: 2935356
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma.
    Paterson AD; Kanis JA; Cameron EC; Douglas DL; Beard DJ; Preston FE; Russell RG
    Br J Haematol; 1983 May; 54(1):121-32. PubMed ID: 6221750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Suppression of severe hypocalcemia associated with malignant lymphoma by intravenous administration of dichloromethylene diphosphonate].
    Tschopp JM; Jung A; Miescher PA
    Schweiz Med Wochenschr; 1981 Oct; 111(44):1655-7. PubMed ID: 6458087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic lymphocytic leukemia and hypercalcemia: treatment with dichloromethylene diphosphonate.
    Siris ES; Grossbard L; Halper JP; Blume RS; Jacobs TP
    Metab Bone Dis Relat Res; 1983-1984; 5(2):61-3. PubMed ID: 6231452
    [No Abstract]   [Full Text] [Related]  

  • 7. [[Clodronate therapy of hypercalcemia caused by hyperparathyroidism].
    Hoffmeyer P; Groebli Y; Spiliopoulos A; Jung A
    Schweiz Med Wochenschr; 1982 Jan; 112(4):118-20. PubMed ID: 6461066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcaemia in a 63 year old man.
    Ranganath L; Semple MJ
    Postgrad Med J; 2000 May; 76(895):309-10, 313-4. PubMed ID: 10775292
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preoperative normalization of hypercalcemia, caused by parathyroid cancer, by intravenous administration of dichloromethylene diphosphonate].
    Conte N; Di Virgilio R; Roiter I
    Minerva Endocrinol; 1984; 9(1):47-8. PubMed ID: 6239086
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of diphosphonates in myeloma.
    Kanis JA; Paterson AD; Russell RG
    Br J Haematol; 1983 Apr; 53(4):688-90. PubMed ID: 6219695
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypercalcemia in malignancies: treatment with dichloromethylene diphosphonate (Cl2MDP).
    Conte N; Di Virgilio R; Roiter I; Caberlotto L
    Tumori; 1985 Feb; 71(1):51-4. PubMed ID: 3157251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dichloromethylene diphosphonate action in hematologic and other malignancies.
    Canfield RE; Siris ES; Jacobs TP
    Bone; 1987; 8 Suppl 1():S57-62. PubMed ID: 2961356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clodronate in hypercalcemia of malignancy.
    Bonjour JP; Rizzoli R
    Calcif Tissue Int; 1990; 46 Suppl():S20-5. PubMed ID: 2137362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton.
    Siris ES; Hyman GA; Canfield RE
    Am J Med; 1983 Mar; 74(3):401-6. PubMed ID: 6219577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of dichloromethylene diphosphonate in metastatic bone disease.
    Jung A; Chantraine A; Donath A; van Ouwenaller C; Turnill D; Mermillod B; Kitler ME
    N Engl J Med; 1983 Jun; 308(25):1499-501. PubMed ID: 6222257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of painful bone lesions and hypercalcemia.
    Ascari E; Attardo-Parrinello G; Merlini G
    Eur J Haematol Suppl; 1989; 51():135-9. PubMed ID: 2534078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with clodronate in patients with hypercalcemia secondary to malignancy.
    Lind L; Wengle B; Ljunghall S
    Ups J Med Sci; 1987; 92(3):259-63. PubMed ID: 2966487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
    Chapuy MC; Meunier PJ; Alexandre CM; Vignon EP
    J Clin Invest; 1980 May; 65(5):1243-7. PubMed ID: 6444955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma.
    Siris ES; Sherman WH; Baquiran DC; Schlatterer JP; Osserman EF; Canfield RE
    N Engl J Med; 1980 Feb; 302(6):310-5. PubMed ID: 6444241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supportive therapy in multiple myeloma.
    Ludwig H; Zojer N
    Recent Results Cancer Res; 2011; 183():307-33. PubMed ID: 21509692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.